May 12, 2020 / 10:15 AM / 16 days ago

BRIEF-Intellia Reports Progress On Crispr/CAS9 AML Cancer Therapy

May 12 (Reuters) - Intellia Therapeutics Inc:

* INTELLIA THERAPEUTICS REPORTS PROGRESS ON CRISPR/CAS9 AML CANCER THERAPY USING PROPRIETARY CELL ENGINEERING PROCESS AT THE 23RD ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE AND CELL THERAPY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below